apceth Biopharma's vision is to improve patients' lives with next-generation cell therapies. Cell and gene therapies have the potential to bring a lasting cure for many diseases that cannot be treated sufficiently today. We are an experienced and certified partner for contract research and contract manufacturing. We produce complex cell and gene therapies according to Good Manufacturing Practice (GMP) for human application. We enjoy an excellent international reputation for quality and reliability. Our customers include both large pharmaceutical companies and innovative biotechnology companies. Since April 2019, apceth Biopharma is a fully owned subsidiary of Hitachi Chemical Co., Ltd. https://www.apceth.com/impressum/
apceth Biopharma's vision is to improve patients' lives with next-generation cell therapies. Cell and gene therapies have the potential to bring a lasting cure for many diseases that cannot be treated sufficiently today. We are an experienced and certified partner for contract research and contract manufacturing. We produce complex cell and gene therapies according to Good Manufacturing Practice (GMP) for human application. We enjoy an excellent international reputation for quality and reliability. Our customers include both large pharmaceutical companies and innovative biotechnology companies. Since April 2019, apceth Biopharma is a fully owned subsidiary of Hitachi Chemical Co., Ltd. https://www.apceth.com/impressum/